ArticleJournal of acquired immune deficiency syndromes (1999)2026
Modeling the Potential Impact of Scaling Up Event-Driven PrEP Among Gay, Bisexual, and Other Men who have Sex with Men.
Article in Journal of acquired immune deficiency syndromes (1999), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
Abstract
backgroundEvent-driven preexposure prophylaxis/PrEP (EDP), or PrEP taken around the time of sex, could be a preferred option over daily PrEP among cisgender gay, bisexual, and other men who have sex with men (MSM). However, recommendations for EDP versus daily dosing require consideration of optimal strategies for HIV prevention based on heterogeneous behavioral and biological PrEP indications.
methodsWe used network-based mathematical HIV transmission modeling to understand the potential population-level impact of implementing EDP alongside daily PrEP using the 2-1-1 dosing schedule: 2 pills on the day of sex, 1 pill a day after, and 1 pill 2 days after. We simulated HIV transmission among 100,000 MSM in Atlanta, Georgia over 10 years. Compared to a baseline scenario with only daily PrEP and no EDP, we tested counterfactual scenarios that increased EDP use by changing initiation rates, expanding EDP to MSM not indicated for daily PrEP, and targeting EDP among MSM with low daily PrEP adherence who discontinued daily PrEP.
resultsIncreasing EDP initiation such that overall PrEP use was nearly double that at baseline (28.5% vs. 16.1%) yielded a percent of infections averted (PIA) of 18.3%. Expanding eligibility for EDP to any sexually active MSM resulted in a PIA of 15.8%. Targeting EDP for MSM discontinuing PrEP did not yield population-level improvements. Increasing initiation of EDP had a greater impact on PIA compared to improving EDP adherence.
conclusionsUsing EDP to improve overall PrEP use resulted in reductions in HIV incidence, while targeted EDP initiation for MSM with low daily PrEP adherence did not improve outcomes over 10 years.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.